• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Int J Infect Dis. Coronavirus disease 2019 in pregnancy

tetano

Editor, Senior Moderator
Int J Infect Dis. 2020 Apr 27. pii: S1201-9712(20)30280-0. doi: 10.1016/j.ijid.2020.04.065. [Epub ahead of print]
Coronavirus disease 2019 in pregnancy.


Qiancheng X[SUP]1[/SUP], Jian S[SUP]2[/SUP], Lingling P[SUP]3[/SUP], Lei H[SUP]2[/SUP], Xiaogan J[SUP]1[/SUP], Weihua L[SUP]1[/SUP], Gang Y[SUP]4[/SUP], Shirong L[SUP]4[/SUP], Zhen W[SUP]1[/SUP], GuoPing X[SUP]5[/SUP], Lei Z[SUP]6[/SUP]; sixth batch of Anhui medical team aiding Wuhan for COVID-19.

Author information




Abstract

OBJECTIVES:

This study aims to compare clinical course and outcomes between pregnant and reproductive-aged non-pregnant women with COVID-19 and assess the vertical transmission potential of COVID-19 in pregnancy.
METHODS:

Medical records of pregnant and reproductive-aged non-pregnant women hospitalized with COVID-19 from January 15 to March 15, 2020, were retrospectively reviewed. The severity of disease, virus clearance time, and length of hospital stay were measured as the primary interest and the vertical transmission potential of COVID-19 was also assessed.
RESULTS:

Eighty-two patients (28 pregnant women, 54 reproductive-aged non-pregnant women) with laboratory confirmed COVID-19 were enrolled in this study. Univariate regression indicated no association between pregnancy and the severity of disease (OR 0.73, 95% CI 0.08-5.15; p=0.76), virus clearance time (HR 1.16, 95% CI 0.65-2.01; p=0.62), and length of hospital stay (HR 1.10, 95% CI 0.66-1.84; p=0.71). There were 22 pregnant women delivered 23 live births either by cesarean section (17, 60.7%) or vaginal delivery (5, 17.9%) and no neonate was infected with SARS-CoV-2.
CONCLUSIONS:

Pregnant women have comparable clinical course and outcomes compared with reproductive-aged non-pregnant women when infected with SARS-CoV-2. No evidence supported vertical transmission of COVID-19 in the late stage of pregnancy including vaginal delivery.
Copyright ? 2020 The Author(s). Published by Elsevier Ltd.. All rights reserved.



KEYWORDS:

COVID-19; SARS-CoV-2; clinical feature; infection; pregnancy; virus


PMID:32353549DOI:10.1016/j.ijid.2020.04.065
 
Back
Top Bottom